Mirena (Levonorgestrel)

Levonorgestrel, the active ingredient in Mirena, is a progestogen presented as a 52 mg intrauterine system for intrauterine use. It provides long‑acting contraception for up to five years and is also indicated for the management of heavy menstrual bleeding in women of reproductive age.

GNH USA supplies Mirena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is distributed under strict quality controls.

Mirena, a levonorgestrel‑releasing intrauterine system, is used in hormonal contraceptive and menstrual‑management pathways.

- Contraception: provides up to five years of highly effective birth control for women of reproductive age. - Heavy menstrual bleeding: reduces menstrual blood loss and may improve anemia. - Endometrial protection: maintains a thin endometrium, lowering the risk of hyperplasia.

Adverse reactions reported with Mirena can be grouped as common and serious or rare.

Common Side Effects: - Irregular bleeding or spotting - Amenorrhea (absence of periods) - Headache - Breast tenderness

Serious or Rare Side Effects: - Pelvic inflammatory disease - Uterine perforation during insertion - Device expulsion

Before insertion and during use, several precautions should be observed.

- Pregnancy screening: confirm the patient is not pregnant prior to insertion. - Infection risk: treat any active pelvic infection before placement. - Uterine anomalies: assess for fibroids, septa or other malformations. - Follow‑up visits: schedule regular checks to verify device position. - Contraindications: avoid in women with known or suspected reproductive‑organ malignancy. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Levonorgestrel may interact with other medicines, requiring attention to certain combinations.

Major Interactions (Avoid): - Enzyme inducers such as rifampicin may reduce contraceptive efficacy. - Antifungal azoles (e.g., ketoconazole) can increase systemic levonorgestrel levels. - Protease inhibitors (e.g., ritonavir) may alter hormone metabolism.

Moderate Interactions (Monitor Closely): - Anticonvulsants like phenytoin or carbamazepine may lower effectiveness. - St. John’s wort may diminish contraceptive protection. - Concurrent hormonal therapies may increase risk of hormonal side effects.